NantHealth Announces New Expanded Coverage with Self-Insured Employers, Insurance Payers, and Health Systems for GPS Cancer...
Publication in Journal of Clinical Oncology demonstrates that Oncotype DX predicts late distant recurrence in breast cancer
Nature Partner Journals Publish Five-year Outcomes Results from SEER Registry Demonstrating Oncotype DX® Accurately...
Guardant Health and Oncotest announce exclusive distribution and marketing partnership for Guardant360 in Israel
Liquid Biopsy May Help Guide Treatment Decisions for Advanced Solid Tumors